 |
|
|
|||||
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each. This transaction highlights investor interest in the agrochemical firm. Mahamaya Lifesciences manufactures pesticide formulations and crop protection products. The company has shown strong financial growth recently. Its shares have performed well since their market debut.
Category:
News and Media
ICICI Prudential AMCs Rs 10,600 crore IPO drew nearly Rs 3 lakh crore in bids, led by strong global and domestic institutional demand. Robust anchor participation underscored confidence, though valuation and OFS structure suggest a steady, not explosive, listing.
Category:
News and Media
Nifty has slipped below 25,900, signalling short-term weakness, but its broader uptrend remains intact, says HDFC Securities Vinay Rajani. He has also flagged 26,060 as the key resistance for a bullish reversal and 25,700 as crucial support. A break below this level could turn the trend into a positional downtrend.
Category:
News and Media
Vedanta shares surged to a 52-week high after the NCLT approved its demerger plan, creating five distinct entities. This approval provides significant relief following earlier government objections. The company is now set to implement the scheme, aiming for focused, sector-leading businesses.
Category:
News and Media
Market participants should brace for a phase where easy returns from broad themes may fade. Selectivity, precise bet sizing, and a sharp bottom-up approach will be crucial for portfolio construction in the coming months. Investors should focus on direct beneficiaries of government initiatives like MSME expansion, with credit and hiring-linked plays showing promise.
Category:
News and Media
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »